Patents by Inventor Bharathi Laxman

Bharathi Laxman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100257617
    Abstract: The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to recurrent gene fusion nucleic acids and transgenic animals comprising recurrent gene fusion nucleic acids.
    Type: Application
    Filed: February 21, 2007
    Publication date: October 7, 2010
    Applicant: Regents of the University of Michigan
    Inventors: Chinnaiyan Arul, Bharathi Laxman, Scott Tomlins, Rohit Mera
  • Patent number: 7332290
    Abstract: The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides gene expression profiles associated with prostate cancers. The present invention also provides novel markers useful for the diagnosis, characterization, and treatment of prostate cancers. In particular, the present invention provides methods and compositions for the detection of ?-methylacyl-CoA racemase (AMACR) in the urine as a marker for prostate cancer detection.
    Type: Grant
    Filed: July 30, 2004
    Date of Patent: February 19, 2008
    Assignee: The Regents of the University of Michigan
    Inventors: Mark A. Rubin, Arul M. Chinnaiyan, Bharathi Laxman, Arun Sreekumar
  • Publication number: 20050136493
    Abstract: The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides gene expression profiles associated with prostate cancers. The present invention also provides novel markers useful for the diagnosis, characterization, and treatment of prostate cancers. In particular, the present invention provides methods and compositions for the use of ?-methylacyl-CoA racemase (AMACR) as a marker for prostate cancer detection and prognosis.
    Type: Application
    Filed: July 30, 2004
    Publication date: June 23, 2005
    Applicant: The Regents of the University of Michigan
    Inventors: Mark Rubin, Arul Chinnaiyan, Bharathi Laxman, Arun Sreekumar
  • Publication number: 20040214233
    Abstract: The present invention relates to automated methods, systems, and apparatuses for protein separation and analysis. In particular, the present invention provides an automated system for the separation, identification, and characterization of protein samples. The present invention thus provides improved methods for the separation and analysis of samples containing a plurality of proteins (e.g., cells).
    Type: Application
    Filed: January 13, 2004
    Publication date: October 28, 2004
    Applicant: The Regents of the University of Michigan
    Inventors: David M. Lubman, Arul M. Chinnaiyan, Arun Sreekumar, Bharathi Laxman, Fang Yan